Jing Long - Shandong Weigao Vice-General Manager of Marketing Management
SHWGY Stock | USD 2.27 0.04 1.79% |
Executive
Mr. Jing Long is Chief Executive Officer of the company since 2018.
Age | 48 |
Tenure | 6 years |
Phone | 86 63 1562 1999 |
Web | https://www.weigaogroup.com |
Shandong Weigao Management Efficiency
The company has return on total asset (ROA) of 0.0604 % which means that it generated a profit of $0.0604 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1276 %, meaning that it generated $0.1276 on every $100 dollars invested by stockholders. Shandong Weigao's management efficiency ratios could be used to measure how well Shandong Weigao manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | EXECUTIVE Age | ||
Juan Serna | AngioDynamics | N/A | |
Wolfgang Becker | Straumann Holding AG | 57 | |
Michael Rider | ResMed Inc | 66 | |
Brian Lloyd | Merit Medical Systems | 63 | |
Leslie Galvin | Repligen | N/A | |
Marcena Clawson | Utah Medical Products | N/A | |
Paul Sumilas | Envista Holdings Corp | N/A | |
Filippo Impieri | Envista Holdings Corp | N/A | |
Claudia Ortiz | Envista Holdings Corp | N/A | |
Saleem Cheeks | AngioDynamics | N/A | |
Brianne McGuire | Nephros | N/A | |
Mark Butler | Merit Medical Systems | N/A | |
Zubair Javeed | Ansell Limited | N/A | |
Andrew Chen | Envista Holdings Corp | N/A | |
Stephen Keller | Envista Holdings Corp | 50 | |
Jim Ellis | ResMed Inc | N/A | |
Dianne Heiler | Repligen | N/A | |
Clay Fradd | ICU Medical | N/A | |
Carlos MD | ResMed Inc | 58 | |
Magda Michna | STAAR Surgical | N/A | |
Brian Koopman | Utah Medical Products | 54 |
Management Performance
Return On Equity | 0.13 | |||
Return On Asset | 0.0604 |
Shandong Weigao Group Leadership Team
Elected by the shareholders, the Shandong Weigao's board of directors comprises two types of representatives: Shandong Weigao inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Shandong. The board's role is to monitor Shandong Weigao's management team and ensure that shareholders' interests are well served. Shandong Weigao's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Shandong Weigao's outside directors are responsible for providing unbiased perspectives on the board's policies.
Junqiang Lu, Ex Director | ||
Shili Ni, Ex Director | ||
Miu Wong, Company Secretary | ||
Hong Ju, Vice-General Manager of the Production and Supply Chain | ||
Rinan Cong, CEO Director | ||
Xue Wu, Chief Officer | ||
Jing Long, Vice-General Manager of Marketing Management |
Shandong Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Shandong Weigao a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.13 | |||
Return On Asset | 0.0604 | |||
Profit Margin | 0.18 % | |||
Operating Margin | 0.22 % | |||
Current Valuation | 6.75 B | |||
Shares Outstanding | 1.13 B | |||
Price To Earning | 19.07 X | |||
Price To Book | 2.18 X | |||
Price To Sales | 0.51 X | |||
Revenue | 13.15 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Shandong Pink Sheet Analysis
When running Shandong Weigao's price analysis, check to measure Shandong Weigao's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Shandong Weigao is operating at the current time. Most of Shandong Weigao's value examination focuses on studying past and present price action to predict the probability of Shandong Weigao's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Shandong Weigao's price. Additionally, you may evaluate how the addition of Shandong Weigao to your portfolios can decrease your overall portfolio volatility.